PR Newswire
28 Mar 2023, 11:43 GMT+10
SYDNEY, March 28, 2023 /PRNewswire/ -- HaemaLogiX Ltd, a clinical stage biotech company developing novel immunotherapies for multiple myeloma, today announced that its anti-KMA CAR-T cell preclinical development has been completed and is the subject of an abstract accepted for poster presentation at the 2023 Annual Meeting of the American Association for Cancer Research (AACR), held 14-19 April in Orange County.
HaemaLogiX's CAR-T is being developed to target Kappa Myeloma Antigen (KMA) a myeloma-specific antigen not found on normal cells. The completed preclinical data demonstrates strong proof of concept to support the use of anti-KMA CAR-T cell therapy for the treatment of patients with myeloma.
The preclinical development of anti-KMA CAR-T forms part of a research collaboration project with the Centre of Excellence in Cellular Immunotherapy at the Peter MacCallum Cancer Centre.
The abstract is available here and the Poster will be made available by AACR and via the HaemaLogiX website shortly after presentation.
POSTER PRESENTATION DETAILS
Title: Cellular immunotherapy targeting kappa myeloma antigen for the treatment of multiple myeloma.
Presenter: HaemaLogiX Chief Scientific Officer Rosanne Dunn
Abstract ID: 4074 / 26
For more information, please contact:
Investors and Partners Bryce Carmine, Chairman and CEO HaemaLogiX Pty Ltd +61 481 344 140 | Media Jane Lowe, Managing Director IR Department +61 411 117 774 |
About HaemaLogiX Ltd - www.haemalogix.com:
Formed in 2014, HaemaLogiX is a public unlisted biotech company researching antibody therapies for multiple myeloma. Multiple myeloma is a haematological (blood) cancer of plasma cells (B cells) that can cause focused damage to a patient's bone marrow. Multiple myeloma is considered treatable but generally incurable. The HaemaLogiX team has a wide range and depth of experience in antibody research, nonclinical & clinical development, manufacturing and commercialisation. The Scientific Advisory Board (SAB) members are internationally recognised experts in monoclonal antibody therapies and haematology. Our current research and clinical trial partners are global leaders in Multiple Myeloma and AL Amyloidosis therapy. HaemaLogiX is located in Sydney, Australia
Get a daily dose of Sydney Sun news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Sydney Sun.
More InformationNEW YORK: This week, the Wall Street Journal (WSJ) reported that U.S. electric vehicle (EV) maker Tesla and Saudi Arabia ...
NEW YORK, New York - Interest rates could stay higher for longer, but there is the possibility of rate cuts ...
STOCKHOLM, Sweden: Days before the Riksbank, Sweden's central bank, is expected to again raise interest rates, the Swedish krona hit ...
NEW ORLEANS, Louisiana: As Midwest farmers prepare to harvest crops and send tons of grain downriver to the Gulf of ...
JAKARTA, INDONESIA: Government data released this week showed that as imports, such as raw materials and capital goods, declined more ...
NEW YORK, New York - U.S. investors fretted Tuesday while the U.S. central bank deliberated on whether to hike interest ...
WARSAW, Poland: As part of European Union (EU) sanctions imposed against Russia over its invasion of Ukraine, Poland banned all ...
MONTGOMERY, Alabama: Last week, Alabama's school chief, Superintendent Eric Mackey, said that under new reading benchmarks to move to fourth ...
WASHINGTON D.C.: Last week, the Federal Reserve said its losses surpassed the US$100 billion mark and will likely continue to ...
ARLINGTON, Virginia: This week, the U.S. State Department approved the potential sale of drone-related munitions and other systems to Canada ...
BETHESDA, Maryland: This week, the US National Institutes of Health (NIH) said that it started early-stage human trials on FluMos-v2, ...
MAUI, Hawaii: Hawaii Governor Josh Green has announced that the death toll from last month's deadly fire on Maui has ...